Missing/wrong data?
Log in to edit
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.
scientific article
Author/s
author: Hanna-Mari Baldauf, Lars Kaderali, Martin Michaelis, Veit Hornung, Federico Comoglio, Alexander F. Yakunin, Hubert Serve, Jindrich Cinatl, Philipp Ströbel
Work details
Publication date
December 19, 2016
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.